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embers of the ﬁbroblast growth factor (FGF)
family and the FGF receptors (FGFRs) have
been implicated in mediating various aspects
of mammary gland development and transformation. To
elucidate the molecular mechanisms of FGFR1 action in
a context that mimics polarized epithelial cells, we have
developed an in vitro three-dimensional HC11 mouse
mammary epithelial cell culture model expressing a
drug-inducible  FGFR1 (iFGFR1). Using this conditional
model, iFGFR1 activation in these growth-arrested and
polarized mammary acini initially led to reinitiation of
M
 
cell proliferation, increased survival of luminal cells, and
loss of cell polarity, resulting in the disruption of acinar
structures characterized by the absence of an empty lu-
men. iFGFR1 activation also resulted in a gain of invasive
properties and the induction of matrix metalloproteinase 3
(MMP-3), causing the cleavage of E-cadherin and in-
creased expression of smooth muscle actin and vimentin.
The addition of a pan MMP inhibitor abolished these
phenotypes but did not prevent the effects of iFGFR1 on
cell proliferation or survival.
 
Introduction
 
The pathways through which FGFs and their receptors signal
appear to play important roles not only in normal development
and wound healing but also in tumor formation and progression
(Powers et al., 2000). To date, 22 distinct FGFs have been dis-
covered that can act in an autocrine or paracrine fashion
through a class of cell-surface tyrosine kinase receptors (RTKs;
Grose and Dickson, 2005). The ligand binding capacity and tis-
sue distribution of each receptor is highly variable (Dailey et
al., 2005).
Several studies have now linked inappropriate expression
of FGFs and their receptors to the development of human
breast cancer (Dickson et al., 2000). For example, in some
breast cancers, FGF receptors (FGFRs) 1, 2, and 4 are ampli-
fied (Penault-Llorca et al., 1995). Thus, a better understanding
of the role of FGF signaling during breast cancer progression
may facilitate the development of cancer therapies to target this
signaling pathway.
The diversity and complexity of FGF ligand and receptor
interactions makes it difficult to delineate the molecular mecha-
nisms of action of individual FGF ligands or receptors, which
determine a specific cellular response. Thus, an inducible FGFR
(iFGFR) was developed as a ligand-independent dimerization
and activation system to study the early events in FGFR sig-
naling and transformation (Welm et al., 2002). In mouse mam-
mary tumor virus–iFGFR1 transgenic mice, acute induction of
iFGFR1 results in increased lateral budding of the mammary
ductal epithelium and sustained activation induces alveolar hy-
perplasia and invasive lesions, which are associated with ECM
remodeling and vascular branching in the stroma adjacent to
these lesions. These data suggest a potential role for FGFs in
initiating branching in the mammary gland and in restructuring
the stroma to provide support for the developing ductal net-
work. In addition, these results indicate that FGFR1 signaling
may play a critical role in early mammary tumor progression.
To date, many of the studies of FGF signaling have been
performed in 3T3 fibroblasts in two-dimensional (2D) culture
systems, and it was not possible to study the effects of this
pathway in a polarized architecture that mimics acinar struc-
tures of mammary epithelial cells in vivo. Unlike monolayer
cultures, mammary epithelial cells grown in three dimensions
recapitulate several features of mammary epithelium in vivo
(Schmeichel and Bissell, 2003; Shaw et al., 2004). Therefore,
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the three-dimensional (3D) culture system has been used as a
unique approach to investigate the signaling pathways involved
in the early progression of cancer (Muthuswamy et al., 2001;
Radisky et al., 2001; Debnath et al., 2003b).
Several human and mouse mammary epithelial cell lines
have been shown to form acinar structures when grown in a
basement membrane matrix (Shaw et al., 2004). In this paper,
we show for the first time that another extensively used immor-
talized murine mammary epithelial cell line, HC11, can form
acinus-like structures containing a single layer of polarized,
growth-arrested cells when grown within a growth factor–reduced
matrix. HC11 cells are a clonal mouse mammary epithelial cell
line derived from a midpregnant mouse mammary gland.
Upon hormonal stimulation, these cells differentiate and ex-
press milk proteins in vitro (Ball et al., 1988). We therefore
combined the well-defined synthetic chemical ligand–induced
dimerization strategy and HC11 3D cell cultures to establish a
new model system to help dissect the molecular mechanisms
through which iFGFR1 activation disrupts the polarized archi-
tecture of acinar units in the mammary gland and promotes an
invasive phenotype.
Using this model system, we demonstrate that iFGFR1
activation rapidly disrupted cell polarity, induced prolifera-
tion, and promoted cell survival. In addition, matrix metallo-
proteinase 3 (MMP-3) expression was induced and appears to
play a critical role during an epithelial-to-mesenchymal transi-
tion (EMT) characterized by cleavage of E-cadherin, expres-
sion of mesenchymal markers, and cell invasion. Importantly,
our data suggest that increased MMP expression by iFGFR1
was critical for EMT but not for regulation of cell survival or pro-
liferation. Furthermore, small interfering RNA (siRNA) targeted
against MMP-3, but not -9, blocked cleavage of E-cadherin.
These studies describe the first-time use of an inducible
dimerization model to study FGFR1 signaling in an HC11 3D
culture system.
 
Results
 
3D culture of HC11 mammary epithelial 
cells
 
We generated 3D acinar structures by plating single HC11 cells
on the matrix. At day 6, immunostaining and confocal imaging
for phosphorylated histone H3 (p-histone H3), a marker of mi-
tosis; 
 
 
 
6 integrin, a basal surface marker (Fig. 1 A); and phos-
pho-ezrin/radixin/moesin (p-ERM), an apical marker (Fig. 1 B),
indicated that the structures consisted of unpolarized prolifera-
tive cells. We did not observe the staining of cleaved caspase 3,
an apoptosis marker, at day 6 (unpublished data). At day 8, api-
cal–basal polarization appeared within the cell clusters before
lumen formation. The absence of p-histone H3 staining (Fig.
1 C) and the lack of increase in the size of the acini after day 8
suggested that the acini had reached a growth-arrested state.
Immunostaining for 
 
 
 
6 integrin and cleaved caspase 3 (Fig. 1 E)
suggested that the acini consisted of two populations of cells: a
polarized outer layer of cells that directly contacted the matrix
and survived and an inner cluster of apoptotic and poorly polar-
ized cells that did not contact the matrix. Additionally, HC11
acini displayed other aspects of polarity, such as basal deposi-
tion of laminin V, a basement membrane component that was
detected by immunostaining with an anti–laminin V antibody
(Fig. 1 F), and enrichment of p-ERM at the apical surface (Fig.
1 D). After 10–12 d in culture, the majority of the acini con-
tained 15–40 polarized cells surrounding an empty lumen.
Polarization of the cells was confirmed by immunostaining for
 
 
 
6 integrin and p-ERM (Fig. 1 G) and laminin V (Fig. 1 H).
These results suggest that HC11 cells grown in three dimen-
sions recapitulate several features of mammary epithelial cells
in vivo, providing the structural and functional context neces-
sary for examining the biological roles of genes during early-
stage tumorigenesis.
Figure 1. HC11 cells form polarized, growth-arrested acini when cultured
on a basement membrane matrix. Representative confocal microscopic im-
ages are shown. Day 6 HC11 acini were immunostained with antiserum
to p-histone H3 (A, green) and  6 integrin (A, red) or p-ERM (B, green).
Day 8 HC11 acini were immunostained with antiserum to p-histone H3
(C, green) and  6 integrin (C, red), p-ERM (D, green), cleaved caspase 3
(E, green) and  6 integrin (E, red), and laminin V (F, green) and cleaved
caspase 3 (F, red). Day 10 HC11 acini were immunostained with anti-
serum to  6 integrin (G, red) and p-ERM (G, green) and to laminin V
(H, green). Bars, 10  m. 
FGFR1 IN A 3D HC11 CELL MODEL • XIAN ET AL.
 
665
 
iFGFR1 activation disrupts HC11 acinar 
morphology
 
To examine the downstream effects of iFGFR1 activation in
HC11 3D cultures, we generated stable cell lines expressing
iFGFR1. Two clones expressing different levels of iFGFR1 as
determined by immunoblotting for expression of HA-tagged
iFGFR1 (R1-high [R1-H] and R1-low [RI-L]) were chosen for
further analysis (Fig. 2 A). To determine whether dimerization of
iFGFR1 in the two clones activates downstream signaling path-
ways, we analyzed whether iFGFR1 induction could activate ex-
tracellular regulated kinase (ERK) in 2D cultures. On AP20187
induction, both clones showed sustained activation of ERK,
which correlated with the level of iFGFR1 expression (Fig. 2, B
and C). This result indicated that both clones transduce signals
downstream of iFGFR1 to activate ERK. Cell cycle analysis was
performed on the clones grown in two dimensions to determine
whether the AP20187-induced iFGFR1 signaling pathway could
also stimulate a biological response, such as proliferation. For
this experiment, the clones were treated with AP20187 in serum-
free medium, and cellular DNA content was determined by
flow cytometry of propidium iodide–stained cells. Both clones
showed a greater than twofold increase in the number of cells in
S phase in response to AP20187 (unpublished data), which was
consistent with previous studies using HC11 cells transiently
transduced with iFGFR1 (Welm et al., 2002). These results sug-
gested that dimerization of iFGFR1 in the two clones was suffi-
cient to stimulate a biological response.
To examine the effects of iFGFR1 activation in preformed
polarized HC11 acini, single cells of each clone were seeded on
the matrix and allowed to grow for 10 d to form growth-arrested
acini. When grown on the matrix in the absence of AP20187, the
HC11 clones expressing iFGFR1 displayed the same growth and
morphogenesis properties as nontransduced HC11 cells (unpub-
lished data). After 10 d, growth-arrested polarized acini had
formed and AP20187 were added to the medium for 5 d. Activa-
tion of iFGFR1 induced striking changes in the morphology of
the acinar structures (Fig. 2 D). In contrast to the untreated
iFGFR1 acini, 
 
 
 
80% of the treated acini displayed dramatically
increased acinar size (
 
 
 
10-fold larger) and an invasive pheno-
type. Immunostaining with the anti–p-histone H3 antibody and
confocal analyses of these structures demonstrated that untreated
iFGFR1 acini remained growth arrested, whereas proliferation
was reinitiated in the treated iFGFR1 acini that now contained lu-
mens that were completely filled with cells (Fig. 2 E). Although
the R1-H and -L clones had similar proliferation properties (not
depicted), their invasive behaviors correlated with their iFGFR1
expression level. In a few acini (5% or less), cells dissociated and
invaded the matrix after 24 h of AP20187 treatment. In 80–90%
of the treated acini, a progressive architectural disruption oc-
curred, and the acini displayed an invasive phenotype after 5 d of
treatment. 5 d after stimulation, the R1-L clone had individual
cells that dissociated from the acini and invaded the matrix,
whereas the R1-H clone had long projections containing multiple
cells that invaded the matrix (Fig. 2 D). The cells in these projec-
tions continued to proliferate (as determined by anti–p-histone
H3 immunostaining) and invade the matrix, which was observed
after 5 d of treatment (Fig. 2 E, arrow). Together, these results
demonstrate that although proliferation in response to iFGFR ac-
tivation was similar in the two clones, the severity of the invasive
phenotype correlated with the level of FGFR1 expression.
 
iFGFR1 activation disrupts polarity, 
prevents luminal apoptosis, reinitiates 
proliferation, and promotes invasion in 
HC11 acini
 
Our previous study of iFGFR1 transgenic mice showed that
iFGFR1 activation prevented apoptosis, induced proliferation,
and altered cell polarity in mammary epithelial cells. Further-
Figure 2. iFGFR1 activation alters HC11 acinar morphogenesis. (A) Two
stable clones of HC11 cells expressing different levels of iFGFR1 (R1-L and
-H) were examined by immunoblotting with anti–HA epitope antibody.
(B) ERK activation of two clones was assessed by immunoblotting with
anti–p-ERK after treatment with AP20187 for 30 min. Equal loading of
protein on the blot was determined by reprobing the membrane with anti-
ERK antibody. (C) Time course of ERK activation after iFGFR1 induction
was examined by immunoblotting using anti–p-ERK antibody. ERK is
shown as a control for equal protein loading. The two clones gave similar
results, so only R1-L is shown here. (D) 10-d-old iFGFR1 acini were treated
with ( ) or without ( ) AP20187 for 5 or 10 d. Brightfield images are
shown. Bars, 50  m. (E) Confocal images of acinar cultures treated for 5 d
and immunostained by anti–p-histone H3 (green) are shown. TOPRO-3
(blue) labeled the nuclei. The arrow indicates where cells continued to pro-
liferate and invade the matrix, which was observed after 5 d of treatment.
Bars, 25  m. 
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more, iFGFR1-induced lesions have invasive characteristics
(Welm et al., 2002). To examine whether iFGFR1 homodimers
were able to activate downstream signaling and recapitulate some
phenotypes of transgenic mice in polarized, growth-arrested 3D
acini, iFGFR1 acini were stimulated with AP20187 for 24 h or 5 d,
and cell polarity, proliferation, and apoptosis were monitored by
immunostaining with the appropriate markers.
The serine/threonine protein kinase Akt (protein kinase B),
a regulator of cellular proliferation and apoptosis (Scheid and
Woodgett, 2001), is a downstream target of FGF signaling. To
examine whether Akt signaling was activated on iFGFR1 induc-
tion in 3D cultures, we performed immunostaining on treated
and untreated iFGFR1 acini using a phosphospecific Akt anti-
body that recognized an activation-specific phosphorylation site
(anti–p-Akt Ser 473; Fig. 3 A, a and b). The untreated acini ex-
hibited a random pattern of Akt activation only in the outer layer
cells that directly contacted the matrix, whereas the treated struc-
tures displayed significantly increased levels of activated Akt
present in both the luminal cells and the outer layer cells. This re-
sult suggests that the iFGFR1 homodimer is able to activate a
physiological FGF signaling pathway in 3D cultures.
To determine whether iFGFR1 activation could reinitiate
proliferation in 3D cultures, we stimulated day 10 iFGFR1
acini with AP20187 for 24 h or 5 d and then immunostained
them with anti–p-histone H3 antibody to detect mitotic cells.
The untreated iFGFR1 acini rarely displayed positive staining
of p-histone H3 (Fig. 3, A [c] and B [c]). 24 h after stimulation,
an approximately eightfold increase in the number of cells
staining positive for p-histone H3 was observed in the treated
iFGFR1 acini compared with untreated acini (Fig. 3, A [d]
and C). This increase in proliferation was still detectable after
5 d of treatment, when we observed an approximately fourfold
increase compared with untreated acini (Fig. 3, B [d] and C).
These data suggest that iFGFR1 activation has the ability to
reinitiate cell proliferation in the growth-arrested HC11 acini.
Negative feedback mechanisms involving Sprouty, Sef, and
Cbl (Hanafusa et al., 2002; Wong et al., 2002; Kovalenko et al.,
2003) may attenuate iFGFR1 signaling after 5 d of treatment,
leading to reduced cell proliferation.
To test whether iFGFR1 activation was able to disrupt
cell polarity in the polarized acini, we performed immunostain-
ing on iFGFR1 acini with antibodies against the polarity mark-
ers 
 
 
 
6 integrin (Fig. 3, A [c and d] and B [c and d]) and p-ERM
(Fig. 3 B, a and b). After 24 h of treatment, cell polarity within
the acini was rapidly disrupted because 
 
 
 
6 integrin staining
was no longer limited to the basal-lateral region as seen in un-
treated acini. In addition, the enriched apical localization of
p-ERM was also disrupted and was now detected around the
entire periphery of the cells (unpublished data). This disruption
of cell polarity persisted after 5 d of treatment. Thus, iFGFR1
activation resulted in a sustained loss of cell polarity.
To determine whether iFGFR1 activation could promote
cell survival in the acini, apoptosis was analyzed by immuno-
staining with an anti–cleaved caspase 3 antibody. In compari-
son with the untreated acini, after 5 d of treatment, a dramatic
decrease in the number of cells staining positive for cleaved
caspase 3 was detected in the luminal cells (Fig. 3 B, e and f).
The increased cell proliferation and inhibition of cell death ap-
pears to account for the increased size and filled lumens of
treated iFGFR1 acini. Therefore, iFGFR1 activation has the
ability to reinitiate cell proliferation and disrupt cell polarity in
these growth-arrested polarized HC11 acini, suggesting that it
can be used to investigate the early stages of tumor progression
induced by iFGFR1 signaling.
Figure 3. iFGFR1 activation inhibits luminal apoptosis,
induces proliferation, promotes cell invasion, and dis-
rupts cell polarity. Two clones gave similar results, so
only representative images of R1-L are shown here.
For each antibody staining,  70 structures from three
independent experiments were examined, and  85%
of them displayed the similar phenotypes. (A) Day 10
iFGFR1 acini were either not treated ( ) or treated
( ) with AP20187 for 24 h. Representative confocal
images of structures immunostained with anti–p-Akt
(Ser 473; a and b, green) or anti–p-histone H3 (c and
d, green) and anti– 6 integrin (c and d, red) are
shown. (B) Day 10 iFGFR1 acini either not treated or
treated with AP20187 for 5 d. Representative confo-
cal images of structures immunostained with antibod-
ies against p-ERM (a and b, green),  6 integrin (c and
d, red) and p-histone H3 (c and d, green), or cleaved
caspase 3 (e and f, green) are shown. TOPRO-3
stained the nuclei (blue). Bars, 25  m. (C) Quantita-
tion of p-histone H3 staining of untreated (UT), 24-h
treated (T1D), and 5-d treated (T5D) acini. The total
number of nuclei and the number of nuclei staining
positive for p-histone H3 were counted in 74 un-
treated acini, 83 24-h–treated acini, and 76 5-d–
treated acini. Using these numbers, the percentage of
p-histone H3–positive cells was calculated. The data
are presented as the mean and SEM of fold change
in the percentage of p-histone H3 positively staining
cells among these three groups from three indepen-
dent experiments. 
FGFR1 IN A 3D HC11 CELL MODEL • XIAN ET AL.
 
667
 
iFGFR1 activation leads to dissociation 
of E-cadherin and 
 
 
 
-catenin from the cell 
membrane and expression of 
mesenchymal markers
 
The invasive behavior of the cells upon iFGFR1 dimerization
suggested that iFGFR1 signaling might affect molecules in-
volved in cell–cell adhesion. To examine whether iFGFR1
activation disrupts membrane localization of E-cadherin and
 
 
 
-catenin, day 10 iFGFR1 acini were stimulated with AP20187
for 5 d and immunostained with anti–E-cadherin and anti–
 
 
 
-catenin antibodies (Fig. 4, A and B). Untreated iFGFR1 acini
exhibited well-defined cell–cell junctions as indicated by mem-
brane localization of E-cadherin and 
 
 
 
-catenin, which were
concentrated toward the basal-lateral region of the membrane.
In the acini with iFGFR1 activation, diffusely localized E-cad-
herin and 
 
 
 
-catenin were detected as indicated by diminished
and punctate staining of both proteins. This finding demon-
strated that localization of these adhesive molecules to the cell–
cell junctions was lost in the architecturally disrupted acini.
FGFR1 has been suggested to be involved in EMT during
mouse mesodermal development (Ciruna et al., 1997; Xu et al.,
1999), and mislocalization and loss of E-cadherin at cell–cell
junctions is an early event that is essential for cell invasion and
EMT (Bracke et al., 1996; Bates and Mercurio, 2005). To investi-
gate whether iFGFR1 activation can promote EMT in the HC11
3D culture system, day 10 iFGFR1 acini treated for 5 d with
AP20187 were immunostained with antibodies to detect expres-
sion of mesenchymal markers such as smooth muscle actin
(SMA) and vimentin (Fig. 4 C, b and c). In contrast to the un-
treated acini that did not express these markers (Fig. 4 C, a), SMA
and vimentin expression were readily detectable in the iFGFR1-
activated acini. This result, together with the acquisition of the in-
vasive phenotype and loss of E-cadherin expression at cell–cell
junctions, suggested that iFGFR1 activation results in EMT.
 
iFGFR1 activation alters the motility of 
monolayer HC11 cells
 
Disruption of cadherin-mediated adhesion has been suggested
to affect the movement of epithelial monolayers (Owens et al.,
2000; Wrobel et al., 2004). Because we also observed loss of
membrane localization of E-cadherin upon iFGFR1 activation
in HC11 cells in 2D cultures (unpublished data), we investi-
gated whether activation of iFGFR1 affected the motility of
HC11 monolayer cells. For this experiment, we examined the
ability of iFGFR1-expressing HC11 cells in monolayer to
break their intercellular contacts and move freely out of the ep-
ithelial sheet to repair a wound in the monolayer in response to
AP20187 treatment (Fig. 5 A). After 20 h, cells expressing
iFGFR1 did not migrate without AP20187 treatment. The R1-L
cells displayed a slower level of migration into the wound
space, whereas the R1-H cells migrated into the wound space
Figure 4. iFGFR1 activation promotes EMT. 10-d-old iFGFR1 acini were
cultured in the media with ( ) or without ( ) AP20187 for 5 d. Two
clones displayed similar EMT phenotype after treatment, so only represen-
tative images of R1-L are shown here. Approximately 90 structures from
three independent experiments were examined, and  80% of them dis-
played the similar phenotypes. Structures were immunostained with anti-
bodies against E-cadherin (A, green),  -catenin (B, green), SMA (C [a and b],
green) and p-histone H3 (C [a and b], red), or vimentin (C, c). TOPRO-3
(blue) marked the nuclei. Arrows indicate where E-cadherin and  -catenin
have dissociated from the cell membrane. Bars, 25  m.
Figure 5. iFGFR1 activation in HC11 cells induces migration. (A) Phase-
contrast images of wound closure of R1-L and -H cells that were incubated
in medium with ( ) or without ( ) AP20187 for 20 h. These images are
representative of three separate experiments. Bars, 20  m. (B) R1-L and -H
cells were induced to migrate toward serum. The migration ability was cal-
culated by dividing the total number of migrating cells of treated R1-L (LT)
and -H cells (HT) by the number of untreated cells (UT) that migrated. Each
bar represents the mean and SEM of samples measured in triplicate. 
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rapidly after stimulation and nearly closed the wound in 20 h.
To further confirm this result, a quantitative transwell migra-
tion assay was performed. Although both R1-L and -H cells
migrated better than untreated cells, 
 
 
 
2.5 times more migrat-
ing cells were detected in the R1-H clone than in the R1-L
clone (Fig. 5 B). Therefore, the level of the motility of iFGFR1
stable clones correlated with the expression level of the
iFGFR1 gene.
 
iFGFR1 activation induces MMP-3 
expression and cleavage of E-cadherin
 
FGF signaling has been reported to induce MMP-3 expression
(Pintucci et al., 2003), and MMP-3 overexpression has been re-
ported to result in E-cadherin cleavage and EMT (Lochter et
al., 1997). We therefore examined the expression level of
MMP-3 after iFGFR1 activation by quantitative RT-PCR (Fig.
6 A). A significant increase in MMP-3 expression was ob-
served after 24 h of iFGFR1 activation in HC11 monolayer
cultures. A similar increase in MMP-9 expression was also
detected (unpublished data). Interestingly, although induction
of MMP-3 and -9 expression was observed in both the R1-H
and -L clones, the level of the induction correlated with the
iFGFR1 gene expression level (unpublished data).
To test whether iFGFR1 activation resulted in cleavage of
E-cadherin, cell lysates and conditioned medium were collected
from iFGFR1 clones in monolayer culture after 4 d of AP20187
treatment. Immunoblotting using antibodies against E-cadherin
on the cell lysates revealed a reduction in the level of full-length
E-cadherin (120 kD) expression after treatment (Fig. 6 B, a).
A 40-kD fragment of E-cadherin was observed in the cell extract
(Fig. 6 B, b), whereas an 80-kD cleaved product of E-cadherin
was detected in the conditioned medium after treatment (Fig.
6 B, c). Total ERK was shown to indicate equal protein loading
from the cell extracts (Fig. 6 B, d), and Ponceau S staining con-
firmed equal loading of the proteins from conditioned medium
(not depicted). Because we did not detect down-regulation of
E-cadherin expression in response to iFGFR1 activation by quan-
titative RT-PCR (unpublished data), rapid loss of full-length
E-cadherin was probably attributable to proteolytic cleavage.
 
The iFGFR1-induced EMT phenotype can 
be blocked by a pan MMP inhibitor and is 
irreversible
 
MMPs are known to promote cellular invasion both in vitro and
in vivo (Egeblad and Werb, 2002). To examine whether the in-
vasive phenotypes induced by iFGFR1 activation are dependent
on MMP activity, 10-d-old iFGFR1 acini were treated with
AP20187 in the absence or presence of a pan MMP inhibitor,
GM6001, for 5 d. In the AP20187-treated iFGFR1 acini, inva-
sion of cells into the matrix was abolished in the presence of the
MMP inhibitor (Fig. 7, A and B). Additionally, immunostaining
for E-cadherin revealed that it was maintained at the cell–cell
junctions in the GM6001-treated cultures but not in control cul-
tures (Fig. 7 C). To determine whether the EMT phenotype was
also prevented, AP20187-treated or AP20187/GM6001-treated
iFGFR1 acini were immunostained with the anti-SMA antibody
(Fig. 7 D). Inhibition of MMP activity abolished SMA expres-
sion in the HC11 acini with activated iFGFR1, suggesting that
MMP activity was required for these cells to undergo EMT.
Interestingly, in the presence of AP20187 and GM6001,
iFGFR1 acini still displayed increased acinar size and filled
lumens. Additionally, immunostaining of AP20187/GM6001-
treated iFGFR1 acini with antibodies to detect cell proliferation,
apoptosis, and polarity showed results similar to those found in
the iFGFR1 acini treated with only AP20187 (unpublished data).
These data suggest that the induction of MMP activity is only
required for iFGFR1 to induce cell invasion and EMT.
To test whether the EMT-like effect induced by iFGFR1 is
reversible, the iFGFR1 acini were treated with AP20187 for 24 h
and then AP20187 was removed and the phenotype was evalu-
ated after 5 d. No reduction in the number of acini displaying the
invasive phenotype was observed (Fig. 7 F). These acini also
showed similar levels of vimentin and SMA staining (unpub-
lished data). This result suggests that the EMT-like effect is not
reversible. Interestingly, although dramatically reduced p-ERK
was observed by immunoblotting after withdrawal of AP20187
for 24 h (Fig. 7 E), similar elevated levels of MMP-3 and -9 ex-
Figure 6. iFGFR1 activation induces MMP-3 expression and triggers
cleavage of E-cadherin. (A) Quantitative RT-PCR demonstrates MMP3 in-
duction after iFGFR1 activation in R1-L cells. The mean and SEM from four
independent experiments are shown. (B) iFGFR1 cells cultured on tissue
culture plastic were serum starved for 16 h and then treated with
AP20187 or ethanol solvent for 4 d. Two clones showed similar results, so
only R1-L results are shown here. (a) Total levels of cytoskeleton-associated
E-cadherin were detected by immunoblotting of lysates using DECMA-1
antibody. (b) Cleaved E-cadherin in the cytosol was detected by immuno-
blotting using an anti–E-cadherin antibody recognizing the cytoplasmic
tail of E-cadherin. (c) The extracellular fragment of E-cadherin found in the
conditioned medium was detected using the DECMA-1 antibody. (d) ERK
is shown as a control for equal protein loading. 
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pression were observed by quantitative RT-PCR compared with
the cells from which AP20187 was not withdrawn (not de-
picted). This suggests that there may be a positive feedback loop
downstream of iFGFR1 signaling to maintain the expression of
target genes even in the absence of continued iFGFR1 activation.
The slightly elevated level of p-ERK observed after AP20187
withdrawal as compared with untreated cells may also be suffi-
cient to maintain the induction of downstream target genes ac-
counting for the lack of reversibility of the EMT phenotype.
 
MMP-3 is essential for E-cadherin 
cleavage induced by iFGFR1 activation
 
To determine whether MMP-3 plays an essential role during
iFGFR1-induced EMT, we performed a test to see whether in-
hibition of MMP-3 expression in the iFGFR1 cells affects a
critical step of EMT, loss of E-cadherin from cell–cell junc-
tions. To do so, predesigned MMP-3 and -9 siRNA pools of
four siRNA duplexes were used. Because a similar EMT effect
was observed in both 2D and 3D cultures after iFGFR1 activa-
tion, the effects of MMP-3 and -9 siRNA pools were examined
in 2D cultures. After siRNA transfection, a significant reduc-
tion in MMP-3 and -9 expression was detected in untreated and
treated cells, respectively, by quantitative RT-PCR. After
AP20187 treatment, MMP-3 siRNA–transfected cells dis-
played induction of MMP-9 expression but little MMP-3 in-
duction (Fig. 8 A). Similarly, MMP-9 siRNA–transfected cells
Figure 7. EMT resulting from iFGFR1 activation in HC11 acini is dependent
on MMP activity and is not reversible. Two clones showed similar results, so
only R1-L results are shown here. (A) 10-d-old iFGFR1 acini were treated
( ) or not treated ( ) with AP20187 and the MMP inhibitor GM6001 for
5 d. Brightfield images of acini are shown. Bars, 25  m. (B) Quantitation
of invasive phenotypes of iFGFR1 acini in the absence of AP20187 (UT),
in the presence of AP20187 (T), or in the presence of AP20187 and
GM6001 (T MMPi). The mean and SEM from three independent experi-
ments are shown. (C and D) Confocal images of day 10 iFGFR1 acini
treated with AP20187 ( AP20187) or with AP20187 and GM6001
( AP20187/GM6001) for 5 d. Structures were stained with TOPRO-3
(C, blue) and anti–E-cadherin (C, green) or with anti-SMA (D, green).
Arrow indicates where E-cadherin expression became punctate or lost.
Bars, 25  m. (E) ERK activation of R1 cells induced with AP20187 for
24 h and then withdrawn (R24h) or not (24h) was assessed by immuno-
blotting with anti–p-ERK. Equal loading of protein on the blot was deter-
mined by reprobing the membrane with anti-ERK antibody. (F) Quantitation
of invasive phenotypes of iFGFR1 acini that were untreated (UT6D),
treated for 6 d (T6D), or withdrawn from AP20187 for 5 d after a 24-h
induction (T1DUT5D). The means and SEMs from three independent ex-
periments are shown.
Figure 8. Suppression of MMP-3 expression inhibits E-cadherin cleavage.
(A) Quantitative RT-PCR demonstrates MMP-3 expression and induction af-
ter iFGFR1 activation (in hours) were significantly reduced in R1 cells
transfected with MMP-3 siRNA pool but not with MMP-9 siRNA pool or
siGLO control siRNA. The mean and SEM from three independent experi-
ments are shown. (B) Quantitation of E-cadherin punctate staining of un-
treated iFGFR1 cells transfected with siGLO and AP20187-treated iFGFR1
cells transfected with siGLO, MMP-3 siRNA, or MMP-9 siRNA. The mean
and SEM from three independent experiments are shown. (C) Confocal
images of the cells immunostained with anti–E-cadherin (green). TOPRO-3
marked the nuclei (blue). siGLO control siRNA displays red fluorescence
signal. Bars, 10  m. 
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displayed induction of MMP-3 expression but little MMP-9
induction (unpublished data). This suggests that the MMP
siRNAs are specific for their appropriate targets. siGLO, an
RNA-induced silencing complex (RISC)–free siRNA, which
was used as control, indicated that the transfection efficiency of
the siRNA reached almost 90%. Additionally, siGLO-trans-
fected cells displayed induction of both MMP-3 and -9 similar
to nontransfected cells.
Interestingly, a significant reduction in the percentage of
cells showing punctate staining of E-cadherin was observed in
AP20187-treated MMP-3 siRNA–transfected iFGFR1 cells
but not in siGLO control or MMP-9 siRNA–transfected R1
cells (Fig. 8, B and C). This suggests that MMP-3, but not -9,
is involved in cleavage of E-cadherin downstream of iFGFR1
activation. These data are consistent with the reported function
of MMP-3 in the other model systems (Lochter et al., 1997;
Noe et al., 2001). More important, they suggest that MMP-3 is
the critical downstream target of iFGFR1 activation involved
in EMT.
 
Discussion
 
We have previously described the AP20187-dependent iFGFR1
dimerization system that was developed and applied to a trans-
genic mouse model (Welm et al., 2002). Although a transgenic
mouse model is critical for understanding certain aspects of
epithelial tumorigenesis, such as the roles of the inflammatory
response and angiogenesis, the complexity of the in vivo envi-
ronment makes it difficult to delineate the molecular mecha-
nisms involved in the early stages of oncogenesis. Therefore,
we analyzed the molecular mechanisms of iFGFR1 in 3D cul-
tures of HC11 mouse mammary epithelial cells to mimic the
conditions under which iFGFR1 is activated in vivo.
There are two distinct stages of phenotypic progression
observed in this 3D culture model: the first stage includes rapid
loss of polarity, reinitiation of proliferation, and reduction of
luminal cell apoptosis (observed 24 h after iFGFR1 activation).
The second stage involves invasion of cells into the surround-
ing matrix and EMT (observed 4–5 d after iFGFR1 activation;
Fig. 9 A).
Although several RTKs, including colony-stimulating
factor receptor (CSF-1R), ErbB2, and Met, have been studied
in MCF10A 3D cultures (Shaw et al., 2004), the present study
is the first time that FGFR1 signaling has been examined in a
3D culture system. In the HC11 model system, iFGFR1 activa-
tion is inducible and allows us to study the consequences of
iFGFR1 signaling with time on cell proliferation and invasion
in the preformed and growth-arrested HC11 acinar structures.
The only other example of using this AP20187-inducible sys-
tem in a 3D culture system is the activation of ErbB2 in
MCF10A mammary acini, which resulted in the formation of
structures containing multiple acinar units with filled lumens
but without invasive properties. Cooperation of the ErbB2 and
TGF
 
 
 
 signaling pathways was required for the sustained, ele-
vated activation of ERK and the induction of migration and inva-
sion of MCF10A cells (Muthuswamy et al., 2001; Seton-Rogers
et al., 2004). This result suggests that coordination of these two
signal transduction pathways is required to promote cell inva-
sion. Thus, it is surprising that FGFR1 signaling can promote
both proliferation and invasion in the absence of other onco-
genic events, and this may be a unique property of this RTK.
Another RTK, CSF-1R, when co-overexpressed with its
ligand in MCF10A 3D cultures, resulted in a cell invasion
phenotype similar to that observed after FGFR1 activation
characterized by loss of E-cadherin from plasma membrane
and release of individual cells into the matrix. However, in this
case no reduction in total E-cadherin was observed. Thus, it was
suggested that other mechanisms, such as an increased rate of
endocytosis or a defect in the recycling of internalized mole-
cules, may be involved in the loss of E-cadherin from the
plasma membrane (Wrobel et al., 2004). Therefore, FGFR1 and
CSF-1R appear to regulate cell invasion through distinct
mechanisms. Although RTKs can activate a similar array of
downstream signaling effectors, including ERK and phos-
phatidylinositol-3 kinase, their phenotypes as determined in
3D cultures appear to be quite distinct (Shaw et al., 2004).
The current study of FGFR1 signaling in 3D cultures supports
this observation.
To understand how iFGFR1 regulates cell invasion, we
first demonstrated that iFGFR1 activation markedly disrupted
cell–cell contacts characterized by the loss of E-cadherin and
Figure 9. Model for iFGFR1-induced cell invasion and EMT in HC11 3D
culture system. (A) Two distinct stages of phenotypic progression were ob-
served in an HC11 3D culture system after iFGFR1 activation. The dashed
line suggests that the phenotypes are still progressing, and the solid line
indicates that the phenotypes have been established. (B) Conditional
dimerization of the iFGFR1 fusion protein by AP20187 activated several
downstream signaling pathways, which may eventually lead to cell polarity
disruption, acinar growth, invasive phenotypes, and EMT. 
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-catenin at the cell membrane. Adherens junctions represent a
powerful invasion suppressor complex in normal mammary as
well as other epithelial cells (Herrenknecht et al., 1991; McCrea
and Gumbiner, 1991).
Multiple mechanisms of inactivation of the E-cadherin–
catenin complex in normal development and tumor formation
have been reported, including genetic mutation, gene inactiva-
tion through methylation, repression of expression by Snail
and other family members, and cleavage by MMPs (Berx et
al., 1996; Bracke et al., 1996; Lochter et al., 1997; Ciruna and
Rossant, 2001). Although it has been proposed that Snail ex-
pression downstream of FGFR1 is required for the normal
repression of E-cadherin expression during early embryonic
development (Ciruna and Rossant, 2001), we did not detect in-
duction of Snail expression or inhibition of E-cadherin expres-
sion by quantitative RT-PCR in our system (unpublished
data). This finding suggests that in the HC11 model during cell
invasion, loss of E-cadherin is regulated through iFGFR1 by
other mechanisms. Interestingly, after iFGFR1 activation, we
observed a rapid increase in Twist expression, a known tran-
scriptional repressor of E-cadherin during EMT (Yang et
al., 2004). Because Twist has also been suggested to func-
tion as a transcriptional activator (Yang et al., 2004), it may
be involved in inducing vimentin expression downstream of
iFGFR1 signaling.
MMP-3 is one MMP that has been suggested to lead di-
rectly or indirectly to the cleavage of E-cadherin (Lochter et
al., 1997; Noe et al., 2001) and is involved in promoting EMT
and invasion in mammary tumor cells (Sternlicht et al., 1999).
It has also been suggested to function through Rac1b and reac-
tive oxygen species to induce expression of Snail and EMT
(Radisky et al., 2005). That the effects of iFGFR1 signaling on
cell invasion are dependent on MMP-3 activity is supported by
several observations. First, quantitative RT-PCR revealed a
rapid and dramatic increase in MMP-3 expression on FGFR1
activation, which was followed by E-cadherin cleavage, de-
tected by immunoblotting. Therefore, in the HC11 model sys-
tem, the decrease in E-cadherin after iFGFR1 activation is not
regulated at the transcriptional level, which is dependent on in-
creased Snail expression but is likely the result of cleavage
by MMP-3. Second, the introduction of MMP-3 siRNA, not
MMP-9 siRNA, into iFGFR1 cells inhibited the cleavage of
E-cadherin, thus demonstrating the important role of MMP-3
during iFGFR1-induced EMT.
In iFGFR1-activated acini, the induction of SMA and vi-
mentin expression was also detected. Expression of these mes-
enchymal markers together with the loss of E-cadherin and
 
 
 
-catenin from cell–cell contacts as well as the invasive behav-
ior of the cells suggest that the HC11 mammary epithelial cells
were converted from an epithelial to a mesenchymal phenotype
after the activation of iFGFR1. Although it has been known that
FGFR1 can stimulate EMT in mesoderm during gastrulation, it
is intriguing to find that FGFR1 activation can also induce EMT
in mammary epithelial cells. EMT is a hallmark of tumor pro-
gression associated with the acquisition of invasive and meta-
static features of breast carcinomas (Thompson et al., 1994;
Birchmeier and Birchmeier, 1995). Abolishment of these phe-
notypes by the pan MMP inhibitor GM6001 further suggests
that MMP activity is required for iFGFR1 signaling to promote
EMT and invasive ability of mammary epithelial cells.
In addition to MMP-3, we also observed induction of
MMP-9 expression and activity after iFGFR1 activation
(Welm et al., 2002). Thus, MMP-9 may function to activate lo-
cal growth factors, stimulate angiogenesis in vivo, and degrade
the ECM during cell invasion, whereas MMP-3 is critical for
the cleavage of E-cadherin. This is another potential mecha-
nism through which FGFR1 may act to promote cell invasion.
It is still not clear how cell polarity, proliferation, and
survival are regulated by iFGFR1. Because the changes in
these cellular processes upon iFGFR1 activation were not
blocked by the addition of the MMP inhibitor (unpublished
data), it is possible that they are regulated by independent sig-
naling cascades downstream of iFGFR1. Therefore, these data
suggest that MMP-3 induction may play an important role
downstream of iFGFR1 during invasion and cell migration but
was not required for iFGFR1-mediated effects on cell prolifer-
ation, cell polarity, and cell survival.
Based on these and previous studies that have reported
the ability of MMP-3 to cleave E-cadherin and promote EMT
(Lochter et al., 1997; Noe et al., 2001), we propose a model
whereby iFGFR1 dimerization activates several downstream
signaling pathways that lead to cell polarity disruption, acinar
growth, and an invasive phenotype (Fig. 9 B). Multiple tran-
scription factors can be activated and bind to the MMP-3 pro-
moter to induce its expression, eventually resulting in increased
MMP-3 activity in mammary epithelial cells. Subsequently,
MMP-3 cleaves E-cadherin at the cell membrane, resulting in
cell invasion and EMT. This may also provide one potential
mechanism by which FGFR1 functions during ductal morpho-
genesis to regulate the invasion of mammary epithelium into
the stromal fat pad. Aberrant regulation of this pathway may
lead to early tumor progression. Thus, these results provide
new insight into the possible mechanisms through which
FGFR1 may contribute to breast cancer progression.
Although the iFGFR1 HC11 3D culture system has been
proven to be an excellent system for studying some aspects of
the FGFR1 signaling pathway (e.g., cell invasion and prolifera-
tion), inflammation and angiogenesis, two processes that are
involved in tumor initiation and progression within the iFGFR1
transgenic mouse model, cannot be studied in this monotypic
HC11 3D culture system. Although it may be possible for some
of these processes to be modeled in organotypic 3D cultures,
further analysis of iFGFR1 in transgenic mice will most likely
be required to characterize the molecular mechanisms that reg-
ulate these processes.
 
Materials and methods
 
Plasmids and cell culture
 
iFGFR1 was cloned into the EcoRI sites of the pBabe-puro using an MfeI
fragment of pMMP-iFGFR1 including the FGFR1 intracellular kinase domain,
two tandem FKBPv (FK506 binding protein) domains, the NH
 
2
 
-terminal
myristoylation, and HA epitope sequences (Welm et al., 2002). HC11
cells were grown in growth media containing RPMI 1640 medium (JRH
Biosciences) supplemented with 10% FBS (JRH Biosciences), 2 mM 
 
L
 
-gluta- 
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mine (JRH Biosciences), 10 ng/ml EGF (Life Technologies), 5 
 
 
 
g/ml insu-
lin (Sigma-Aldrich), and 50 
 
 
 
g/ml gentamicin (Sigma-Aldrich). The 293T
cell growth media contained DMEM (GIBCO BRL), 10% FBS, and 50
 
 
 
g/ml gentamicin.
 
Generation of HC11s expressing iFGFR1
 
Cell transduction was done as described previously (Welm et al., 2002).
Stable populations were obtained by selection with 2 
 
 
 
g/ml puromycin
(Sigma-Aldrich). iFGFR1 expression was confirmed by immunoblotting.
The selected clonal cell lines R1-H and -L were routinely grown in the me-
dium with 2 
 
 
 
g/ml to maintain selection pressure. Serum starvation media
for HC11 cells contained only RPMI supplemented with either 30 nM
AP20187 (Ariad Pharmaceuticals) in ethanol or an equal volume of etha-
nol diluent alone as control.
 
Morphogenesis assay
 
HC11 cells were treated with trypsin and resuspended in growth medium.
The cells were pelleted and resuspended in assay medium (RPMI supple-
mented with 2% FBS, 2 mM 
 
L
 
-glutamine, 2.5 ng/ml EGF, 5 
 
 
 
g/ml insulin,
and 50 
 
 
 
g/ml gentamicin) at a concentration of 25,000 cells/ml. Eight-
chambered RS glass slides (Nalgene) were coated with 40 
 
 
 
l Matrigel
basement membrane matrix (CLONTECH Laboratories, Inc.) per well and
left to solidify for 15 min. The cells were mixed 1:1 with assay medium
containing 4% Matrigel, and 400 
 
 
 
l was added to each chamber of the
Matrigel-coated eight-chambered slide. Assay medium was replaced ev-
ery 4 d. For stimulation with AP20187, the assay medium was replaced
with the assay medium containing 100 
 
 
 
M AP20187 at day 10. For stim-
ulation with AP20187 and GM6001 (Sigma-Aldrich), the assay medium
was replaced with the assay medium containing 100 
 
 
 
M AP20187 and
10 
 
 
 
M GM6001 at day 10.
 
Wound healing assay
 
HC11 cells were seeded on glass coverslips at 5 
 
 
 
 10
 
4
 
 cells per well and
grown to confluence before overnight starvation in RPMI. A single wound
was introduced in the monolayer using a micropipette tip, and the medium
was replaced with RPMI supplemented with either 30 
 
 
 
M AP20187 in
ethanol or an equal volume of ethanol diluent. Wound closure was moni-
tored for 20 h.
 
Migration assay
 
0.5 ml of serum was added to the wells of a 12-well plate (Falcon). 5,000
R1-L and -H cells were plated in 0.5 ml of serum-free RPMI in 12-well for-
mat cell culture inserts containing 8-
 
 
 
m pores (Falcon). After a 20-h incu-
bation, cells that had not migrated through the filters were removed using
a cotton swab and the filters were stained with hematoxylin.
 
Immunoblot analysis
 
The following antibodies were used for immunoblot analysis: phospho-ERK
and ERK (Cell Signaling); HA epitope (Santa Cruz Biotechnology, Inc.);
DECMA-1, a rat monoclonal antibody that recognizes the extracellular
domain of murine E-cadherin (Sigma-Aldrich); and E-cadherin, which rec-
ognizes the cytoplasmic tail of E-cadherin (Transduction Laboratories).
Protein extracts from cultured cells were isolated by lysing the monolayer
cell with RIPA buffer (1% Triton X-100, 1% NaDOC, 0.1% SDS, 20 mM
Tris HCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA) supplemented with
Protease cocktail inhibitor (Roche) and phosphatase inhibitor (1 mM
NaVO
 
4
 
 and 1 mM NaF) for 15–30 min at 4
 
 
 
C. Lysates were cleared for
15 min at 13,000 rpm, and supernatants were collected. Conditioned me-
dium from monolayer cell cultures were harvested, centrifuged at 2,000 
 
g
 
for 15 min, and passed through a 0.22-
 
 
 
m filter, concentrated by Centri-
con (Millipore). Protein extracts and concentrated condition medium were
quantitated by Bradford assay (Bio-Rad Laboratories). Proteins (30 
 
 
 
g)
were resolved by SDS-PAGE and transferred onto polyvinylidene fluoride
membranes (Millipore). For immunostaining, blots were quenched with 5%
nonfat dry milk in TBS containing 0.5% Tween 20. The membranes were
incubated with primary antibody at a dilution of 1:1,000, followed by three
5-min washes and incubation with horseradish peroxidase–conjugated sec-
ondary antibodies at a dilution of 1:5,000. Chemiluminescence was devel-
oped based on the manufacturer’s protocol (Pierce Chemical Co.).
 
Indirect immunofluorescence and image acquisition
 
The following primary antibodies were used for indirect immunofluores-
cent detection of specific antigens: anti–p-histone H3 (Ser10; Upstate Bio-
technology); anti–cleaved caspase 3 (Asp175; Cell Signaling); anti–phos-
pho-ezrin (Thr567)/radixin (Thr564)/moesin (Thr558) (Cell Signaling);
anti-CD49f (Cell Signaling); anti–laminin V (Chemicon); anti–E-cadherin
(Transduction Laboratories); anti–
 
 -catenin (nonphosphorylated; Upstate
Biotechnology); anti–phospho-Akt (Ser473; Cell Signaling). All first anti-
bodies were used at a dilution of 1:200. Secondary antibodies were as
follows: anti-mouse or anti-rabbit Texas red; anti-mouse or anti-rabbit cou-
pled with Alexa Fluor dyes; anti-rat Texas red (Invitrogen). All secondary
antibodies were used at a dilution of 1:500. Nuclei were stained with
TOPRO-3 (Invitrogen). Immunostaining was performed as previously de-
scribed (Debnath et al., 2003a). Confocal analyses were performed using
a laser-scanning confocal microscope (model 510; Carl Zeiss MicroImaging,
Inc.). The acquisition software used was LSM image browser (Carl Zeiss
MicroImaging, Inc.). Phase-contrast images were captured using an in-
verted microscope (CK40-SLP; Olympus) and video camera (CCD-IRIS/
RGB; Sony). The acquisition software used was Photoshop 5.0 (Adobe).
Quantitative RT-PCR
RNA was extracted from monolayer cells using Trizol as recommended by
the manufacturer (Invitrogen). 5- g samples of RNA were treated with
DNase I as recommended by the manufacturer (Invitrogen) followed by
generation of cDNA using Superscript II (Invitrogen). One tenth of the final
reaction volume was used in quantitative PCR reactions as described
previously (Yuen et al., 2002) containing 1 mM MgCl2, platinum Taq
(Invitrogen), and 1  SYBR green (Invitrogen). PCR was performed using
a thermocycler (ABI PRISM 7500; Applied Biosystems) with the following
cycles: 94 C for 30 s, 55 C for 30 s, and 72 C for 34 s for 40 cycles. Rela-
tive quantitation of MMP-3 gene expression was calculated and normalized
to cyclophilin expression levels using the 2
   Ct method (Livak and Schmitt-
gen, 2001). The following primer sequences were used: for MMP-3, 5 -TCC-
ATGGAGCCAGGATTTC-3  and 5 -TGCGAAGATCCACTGAAGAAGT-3 
(designed by F. Behbod, Baylor College of Medicine, Houston, TX), and for
cyclophilin, 5 -TGAGCACTGGGGAGAAAGG-3  and 5 -TTGCCATCCAG-
CCACTCAG-3 . MMP-9 primers were purchased from Superarray.
siRNA
SMARTpool siRNA for MMP-3 and -9 and siGLO RISC-free siRNA as the
control were introduced into subconfluent (75–80%) HC11 cells using
DharmaFECT transfection reagent (Dharmacon) according to the manufac-
turer’s instructions. After 24 h, the media were changed to RPMI, and the
cells were starved overnight. The media were replaced with RPMI supple-
mented with either 30  M AP20187 in ethanol or an equal volume of eth-
anol diluent the following day. After the induction for 48 h, the cells were
collected for RNA analysis and immunostaining.
Online supplemental material
Fig. S1 shows untreated or treated R1-L and -H acini at low magnification.
Online supplemental material is available at www.jcb.org/cgi/content/
full/jcb.200505098/DC1.
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